S32 Preclinical and toxicological assessments of the novel orally bioavailable PPAR ligand GED-0507-34-Levo for the treatment of inflammatory bowel disease
C. Rousseaux, C. Dubuquoy, S. Bellinvia, F. Viti, J.F. Colombel, P. Chavatte, P. Desreumaux
{"title":"S32 Preclinical and toxicological assessments of the novel orally bioavailable PPAR ligand GED-0507-34-Levo for the treatment of inflammatory bowel disease","authors":"C. Rousseaux, C. Dubuquoy, S. Bellinvia, F. Viti, J.F. Colombel, P. Chavatte, P. Desreumaux","doi":"10.1016/S1873-9954(10)70059-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100770,"journal":{"name":"Journal of Crohn's and Colitis Supplements","volume":"4 1","pages":"Page 31"},"PeriodicalIF":0.0000,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1873-9954(10)70059-8","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Crohn's and Colitis Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1873995410700598","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
